Sudden cardiac arrest in hypertrophic cardiomyopathy with dynamic cavity obstruction: The case for a

Cosmin Balan1, Adrian View-Kim Wong1

  • 1Department of Critical Care Medicine, Oxford University Hospitals NHS Foundation Trust, UK.

Insights

This case study shows that avoiding catecholamines, like beta-blockers, can help stabilize patients with cardiac arrest and specific heart conditions. This approach aids cardiovascular stability by increasing heart filling.

Area of Science:

  • Critical care medicine
  • Cardiology
  • Pharmacology

Background:

  • Catecholamines are standard in treating shock but can cause harm.
  • A paradigm shift acknowledges catecholamine-induced 'death spirals' in critical care.
  • Refractory ventricular fibrillation requires prolonged resuscitation efforts.

Observation:

  • A 21-year-old male experienced out-of-hospital cardiac arrest with prolonged resuscitation (70 min).
  • Echocardiography revealed severe left ventricular hypertrophy and dynamic mid-cavity obstruction.
  • The patient presented with akinetic apical pouching post-resuscitation.

Findings:

  • A decatecholaminised strategy was implemented.
  • Beta-blockers were used to augment left ventricular end-diastolic volume.
  • Cardiovascular stability was achieved with this management approach.

Implications:

  • This case suggests a decatecholaminised strategy may be beneficial in specific shock states.
  • Managing left ventricular hypertrophy and dynamic obstruction requires tailored hemodynamic support.
  • Further research into non-catecholamine strategies for refractory shock is warranted.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
530
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
591
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
593
Oral Cavity01:11

Oral Cavity

The oral cavity, or the mouth, is a complex structure in humans that plays a vital role in our day-to-day lives. Its role is not only in chewing and swallowing food; it also plays a role in speech and facial expressions.
Teeth: The teeth are the hardest structures in our bodies. Humans have two sets of teeth throughout their lifetime: deciduous (baby) teeth and permanent teeth. Each tooth consists of several parts: the crown (visible part), the root (embedded in the jaw), enamel (hard outer...
3.2K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
470
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
620